ACLY and neoplasm: As key rate-limiting enzyme in de novo fatty acid synthesis, silencing ACLY can inhibit the proliferation of multiple tumor cells lines, and exogenous supplementation with fatty acids or cholesterol can partially counteract the proliferation inhibition effect (40, 41).